Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 50

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 16
Chunk 50
---
,621,463 and the exercise price of the Class G Common Stock Warrants was reset from $16.00 to $3.7596.

 F-18

7. Preferred StockRevelation Authorized Preferred StockThe Company is authorized under its articles of incorporation, as amended, up to 5,000,000 shares of preferred stock, which may be issued as designated by the Board of Directors without stockholder approval. As of December 31, 2024 and as of the date of this Report, there were no shares of preferred stock issued and outstanding.Series A Preferred StockOn December 19, 2022, the Company closed the sale of one share of the Company’s Series A Preferred Stock, par value $0.001 per share, to its Chief Executive Officer for $5,000.00. The outstanding share of Series A Preferred Stock was automatically redeemed for $5,000.00 on January 30, 2023 upon the effectiveness of the Certificate of Amendment implementing the reverse stock split and the increase in authorized shares of common stock of the Company.

8. Common StockThe Company is authorized under its articles of incorporation, as amended, to issue up to 500,000,000 shares of common stock, par value $0.001 per share.Common Stock Issuance during the year ended December 31, 2023On February 13, 2023, the Company issued 6,017 shares of its common stock in connection with the February 2023 Public Offering. The Company received net cash proceeds of $14.0 million.From February 14, 2023 to April 6, 2023, the Company issued 699 shares of common stock in connection with notices of cash exercise for Class C Pre-Funded Warrants issued in connection with the February 2023 Public Offering with a total purchase price of $33.64.From March 13, 2023 to June 30, 2023, the Company issued 4,948 shares of common stock in connection with notices of alternative cashless exercise for the Class C Common Stock Warrants issued in connection with the February 2023 Public Offering.On April 18, 2023, the Company issued 8 shares of common stock in connection with vested Rollover RSU awards.Common Stock Issuance during the year ended December 31, 2024On January 29, 2024, the Company issued 212 shares of common stock in connection with notices of alternative cashless exercise for the Class C